STOCK TITAN

Kineta, Inc. - $KA STOCK NEWS

Welcome to our dedicated page for Kineta news (Ticker: $KA), a resource for investors and traders seeking the latest updates and insights on Kineta stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Kineta's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Kineta's position in the market.

Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.99%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.13%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.95%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.25%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-14.74%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
34.37%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.25%
Tags
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.74%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.32%
Tags
conferences
Kineta, Inc.

Nasdaq:KA

KA Rankings

KA Stock Data

5.82M
6.59M
29.25%
12.05%
0.56%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
MERCER ISLAND

About KA

proteostasis therapeutics is discovering and developing novel small molecule therapeutics designed to control the body’s protein homeostasis, or proteostasis network. the proteostasis network maintains the body’s natural balance of proteins to protect us from numerous diseases. these novel therapies, or proteostasis regulators, are designed to treat multiple genetic and degenerative disorders associated with deficiencies of the proteostasis network, such as alzheimer’s disease, emphysema, huntington’s disease, and type ii diabetes.